Stock Yards Bank & Trust Co. Has $1.23 Million Holdings in Novartis AG (NYSE:NVS)

Stock Yards Bank & Trust Co. trimmed its holdings in Novartis AG (NYSE:NVS) by 34.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,682 shares of the company’s stock after selling 6,605 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Novartis were worth $1,234,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of NVS. Union Bancaire Privee UBP SA acquired a new position in shares of Novartis in the 4th quarter valued at approximately $27,000. Legacy Investment Solutions LLC bought a new stake in shares of Novartis during the third quarter worth $28,000. Fortitude Family Office LLC increased its position in shares of Novartis by 503.8% during the third quarter. Fortitude Family Office LLC now owns 320 shares of the company’s stock worth $37,000 after acquiring an additional 267 shares in the last quarter. Clean Yield Group bought a new stake in Novartis in the 3rd quarter valued at $43,000. Finally, Brooklyn Investment Group acquired a new stake in shares of Novartis in the 4th quarter valued at about $55,000. 13.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently issued reports on NVS. StockNews.com downgraded Novartis from a “strong-buy” rating to a “buy” rating in a report on Friday. Erste Group Bank restated a “hold” rating on shares of Novartis in a report on Tuesday, November 19th. HSBC cut shares of Novartis from a “hold” rating to a “reduce” rating in a report on Wednesday, December 4th. Finally, BMO Capital Markets raised their price objective on Novartis from $118.00 to $120.00 and gave the company a “market perform” rating in a research report on Wednesday, October 30th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $123.38.

Novartis Trading Up 0.8 %

NVS opened at $105.54 on Tuesday. The company has a quick ratio of 0.90, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. Novartis AG has a twelve month low of $92.35 and a twelve month high of $120.92. The stock has a market capitalization of $215.72 billion, a price-to-earnings ratio of 17.95, a P/E/G ratio of 1.51 and a beta of 0.58. The company has a 50-day simple moving average of $100.10 and a 200 day simple moving average of $108.43.

Novartis (NYSE:NVS) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.18. Novartis had a net margin of 23.56% and a return on equity of 37.79%. Analysts predict that Novartis AG will post 8.34 EPS for the current fiscal year.

About Novartis

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology.